AR018465A1 - ORAL SOLID PHARMACEUTICAL COMPOSITION, USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION, MODULATION OR TREATMENT OF VISCERAL PAIN OR INCOMODITY, FOR THE MODULATION OF SENSITIVITY OR PERCORIAL VISCERAL PERCORIAL SENSITIVITY, - Google Patents

ORAL SOLID PHARMACEUTICAL COMPOSITION, USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION, MODULATION OR TREATMENT OF VISCERAL PAIN OR INCOMODITY, FOR THE MODULATION OF SENSITIVITY OR PERCORIAL VISCERAL PERCORIAL SENSITIVITY,

Info

Publication number
AR018465A1
AR018465A1 ARP990104165A AR018465A1 AR 018465 A1 AR018465 A1 AR 018465A1 AR P990104165 A ARP990104165 A AR P990104165A AR 018465 A1 AR018465 A1 AR 018465A1
Authority
AR
Argentina
Prior art keywords
percorial
modulation
sensitivity
visceral
composition
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en
Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR018465A1 publication Critical patent/AR018465A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a una composicion farmacéutica, en particular a una composicion para administrar agentes activos que sonpobremente solubles en medios acuosos, y/o que son sensibles al ácido.The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents that are poorly soluble in aqueous media, and / or that are sensitive to acid.

ARP990104165 1998-08-21 1999-08-19 ORAL SOLID PHARMACEUTICAL COMPOSITION, USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION, MODULATION OR TREATMENT OF VISCERAL PAIN OR INCOMODITY, FOR THE MODULATION OF SENSITIVITY OR PERCORIAL VISCERAL PERCORIAL SENSITIVITY, AR018465A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818340.3A GB9818340D0 (en) 1998-08-21 1998-08-21 Organic compounds
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds

Publications (1)

Publication Number Publication Date
AR018465A1 true AR018465A1 (en) 2001-11-14

Family

ID=37001080

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP990104165 AR018465A1 (en) 1998-08-21 1999-08-19 ORAL SOLID PHARMACEUTICAL COMPOSITION, USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION, MODULATION OR TREATMENT OF VISCERAL PAIN OR INCOMODITY, FOR THE MODULATION OF SENSITIVITY OR PERCORIAL VISCERAL PERCORIAL SENSITIVITY,
ARP010103838A AR030340A2 (en) 1998-08-21 2001-08-10 METHOD TO PREVENT, MODULATE, OR TREAT VISCERAL PAIN OR DISORDER, TO MODULATE VISCERAL SENSITIVITY OR PERCEPTION, TO IMPROVE THE SENSORY PERCEPTION OF RECTAL DISTENSION, OR TO TREAT ANAL AND AGONISTIC CONTINENCE DIFFERENCES, AGONIST RECORDER 5 WHAT IS USED AND

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP010103838A AR030340A2 (en) 1998-08-21 2001-08-10 METHOD TO PREVENT, MODULATE, OR TREAT VISCERAL PAIN OR DISORDER, TO MODULATE VISCERAL SENSITIVITY OR PERCEPTION, TO IMPROVE THE SENSORY PERCEPTION OF RECTAL DISTENSION, OR TO TREAT ANAL AND AGONISTIC CONTINENCE DIFFERENCES, AGONIST RECORDER 5 WHAT IS USED AND

Country Status (5)

Country Link
AR (2) AR018465A1 (en)
CO (1) CO5130010A1 (en)
MY (2) MY152490A (en)
PE (1) PE20000865A1 (en)
TW (1) TWI238725B (en)

Also Published As

Publication number Publication date
PE20000865A1 (en) 2000-09-07
TWI238725B (en) 2005-09-01
AR030340A2 (en) 2003-08-20
MY152490A (en) 2014-10-15
CO5130010A1 (en) 2002-02-27
MY128958A (en) 2007-03-30

Similar Documents

Publication Publication Date Title
HUP0201877A2 (en) Fast-dispersing dosage forms containing fish gelatin
HUP0302086A2 (en) Oral pharmaceutical composition with a delayed action and process for its preparation
DE60121570D1 (en) ORAL FASCINATING, FIXED PHARMACEUTICAL FORMS TO BE APPLIED ORIGINALLY
AR012927A1 (en) A PHARMACEUTICAL COMPOSITION, A PHARMACEUTICAL DOSAGE FORM, THE USE OF SUCH COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND A FORM OF PHARMACEUTICAL PRESENTATION FOR COMMERCIAL SALE
HUP0301868A2 (en) Pharmaceutical composition comprising a factor viia and a factor xiii
DE60115029D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES
ATE224717T1 (en) ORAL MEDICINAL PREPARATIONS CONTAINING A BENZHYDRYLPIPERAZINE AND A CYCLODEXTRIN
HUP0004383A2 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
DE59707812D1 (en) GALENIC FORMULATION CONTAINING OPIOIDANTAGONISTS
HUP0203451A2 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
ATE202926T1 (en) PHARMACEUTICAL EFFECTIVE PREPARATIONS CONTAINING BIODEGRADABLE MICROCAPSULES FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS
AR032293A1 (en) PHARMACEUTICAL CASE
DE69519685D1 (en) ORAL MEDICINAL PRODUCT WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES
YU8701A (en) New oral formulation
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
ATE243504T1 (en) CEFADROXIL MONOHYDRATE TABLET FORMULATION
ATE298324T1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE60102590T2 (en) PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES
AR018465A1 (en) ORAL SOLID PHARMACEUTICAL COMPOSITION, USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION, MODULATION OR TREATMENT OF VISCERAL PAIN OR INCOMODITY, FOR THE MODULATION OF SENSITIVITY OR PERCORIAL VISCERAL PERCORIAL SENSITIVITY,
ATE234096T1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION CONTAINING THE ACTIVE INGREDIENT MORPHINE-6-GLUCURONIDE
AR011707A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THYROSINE AND AN OPTIONALLY MODIFIED ALLERGEN, PROCEDURE FOR ITS PREPARATION AND USE OF IT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
ECSP993104A (en) NEW ORAL FORMULATION
CR6300A (en) NEW ORAL FORMULATION
FR2735695B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING, AS ACTIVE INGREDIENT, MANGIFERIN OR DERIVATIVES THEREOF

Legal Events

Date Code Title Description
FG Grant; registration